Shares of Zimmer Biomet have moved -1.1% today, and are now trading at a price of $102.88. In contrast, the S&P 500 index saw a 1.0% change. Today's trading volume is 545,686 compared to the stock's average volume of 1,448,492.
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. Based in Warsaw, United States the company has 17,000 full time employees and a market cap of $20,380,114,944. Zimmer Biomet currently offers its equity investors a dividend that yields 0.9% per year.
The company is now trading -7.07% away from its average analyst target price of $110.71 per share. The 24 analysts following the stock have set target prices ranging from $96.0 to $130.0, and on average give Zimmer Biomet a rating of buy.
Over the last 12 months ZBH shares have declined by -0.0%, which represents a difference of -15.3% when compared to the S&P 500. The stock's 52 week high is $114.72 per share and its 52 week low is $89.22. With its net margins declining an average -5.0% over the last 6 years, Zimmer Biomet declining profitability gives us reason to believe its stock price will continue to underwhelm.
| Date Reported | Total Revenue ($ k) | Net Profit ($ k) | Net Margins (%) | YoY Growth (%) |
|---|---|---|---|---|
| 2024 | 7,678,600 | 903,800 | 12 | -14.29 |
| 2023 | 7,394,200 | 1,024,000 | 14 | 366.67 |
| 2022 | 6,939,900 | 231,400 | 3 | -50.0 |
| 2021 | 6,827,300 | 401,600 | 6 | 400.0 |
| 2020 | 6,127,500 | -138,900 | -2 | -112.5 |
| 2019 | 6,960,600 | 1,131,600 | 16 |
